Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species
Viruses · 2025
DOI: 10.3390/v17050716 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Viruses, 2025. Verfasst von Leira Fernández-Bastit und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (…. Hauptthemen laut MEDLINE: Antibodies, Viral, SARS-CoV-2, COVID-19, COVID-19 Serological Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BBVA Foundation, Crowdfunding, #Yomecorono.
Abstract (Originalsprache)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the coronavirus disease 19 (COVID-19) pandemic, significantly impacting global health, economies, and social stability. In February 2020, the first cases of SARS-CoV-2 infections in animals were documented, highlighting the potential risks posed by regular human–animal interactions in facilitating viral transmission. In consequence, it is essential to validate surveillance methods for SARS-CoV-2 in animals. In the present study, 101 sera from different animal species (36 cats, 41 dogs, 4 ferrets, 10 wild boar, 6 domestic goats, and 4 lions) were tested using three different ELISA kits to evaluate humoral responses against SARS-CoV-2. ELISA results were compared and correlated with a pseudovirus neutralization test (pVNT), considered as the reference assay. ELISA-1, targeting the receptor binding domain (RBD) neutralizing antibodies (nAbs) of SARS-CoV-2, exhibited the highest diagnostic performance, and proved to be a reliable tool for initial screenings in high-throughput animal studies. In contrast, ELISA-2 (also targeting RBD nAbs) and ELISA-3 (targeting nucleoprotein antibodies) demonstrated lower sensitivity for detecting seropositive animals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Spain.
- IRTA, Animal Health, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Spain.
- IrsiCaixa, 08916 Badalona, Spain.
- University of Vic-Central University of Catalonia (UVic-UCC), Vic, 08500 Barcelona, Spain.
- Infectious Disease Networking Biomedical Research Center (CIBERINFEC), Carlos III Health Institute, 28029 Madrid, Spain.
- Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916 Badalona, Spain.
ORCID-Profile: Edwards Pradenas, Julià Blanco, Júlia Vergara-Alert, Joaquim Segalés
Förderung
- BBVA Foundation
- Crowdfunding
- #Yomecorono
- CERCA Programme/Generalitat de Catalunya
Zitieren
APA
Fernández-Bastit, L., Marfil, S., Pradenas, E., Blanco, J., Vergara-Alert, J., & Segalés, J. (2025). Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species. Viruses. https://doi.org/10.3390/v17050716
Vancouver
Fernández-Bastit L, Marfil S, Pradenas E, Blanco J, Vergara-Alert J, Segalés J. Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species. Viruses. 2025. doi:10.3390/v17050716
BibTeX
@article{FernndezBastit2025,
author = {Fernández-Bastit, Leira and Marfil, Sílvia and Pradenas, Edwards and Blanco, Julià and Vergara-Alert, Júlia and Segalés, Joaquim},
title = {Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17050716}
}
EUVIMED